“…In addition, some researchers have built nomograms to predict long-term survival of particular patient groups, including SCLC patients with metastasis and combined SCLC patients [ 38 , 39 ]. To evaluate the efficacy of different treatments, nomograms can also be established to evaluate the survival of SCLC patients after radiotherapy, chemotherapy, or surgery [ 37 , 40 , 41 ]. So far, there have been three nomograms built to predict the overall survival of SCLC patients after surgery, where LODDS was not calculated and incorporated into the models.…”